Clinical Trial Results:
Efficacy and safety of ODM-101 compared to a standard combination (Stalevo®); a randomised, double-blind, crossover, proof of concept study in patients with Parkinson’s disease and end-of-dose motor fluctuations.
Summary
|
|
EudraCT number |
2010-022200-46 |
Trial protocol |
FI LV LT DE |
Global completion date |
07 Aug 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
02 Sep 2016
|
First version publication date |
02 Sep 2016
|
Other versions |
|
Summary report(s) |
EFFICACY AND SAFETY OF ODM-101 COMPARED TO A STANDARD |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.